|
1) McGuirk P, Higgins SC, Mills KH. The role of regulatory T cells in respiratory infections and allergy and asthma. Curr Allergy Asthma Rep. 2010; 10: 21-8
|
|
|
|
2) Koch MA, Tucker-Heard G, Perdue NR, et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol. 2009; 10: 595-602
|
|
|
|
|
|
3) Garin MI, Chu CC, Golshayan D, et al. Galectin-1: a key effector of regulation mediated by CD4＋CD25＋ T cells. Blood. 2007; 109: 2058-65
|
|
|
|
|
|
4) Shalev I, Liu H, Koscik C, et al. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glom-erulonephritis. J Immunol. 2008; 180: 249-60
|
|
|
|
|
|
5) Onishi Y, Fehervari Z, Yamaguchi T, et al. Foxp3＋ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A. 2008; 105: 10113-8
|
|
|
|
|
|
6) Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3＋ regulatory T cell function. Science. 2008; 322: 271-5
|
|
|
|
|
|
7) Liang B, Workman C, Lee J, et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol. 2008; 180: 5916-26
|
|
|
|
|
|
8) Ling EM, Smith T, Nguyen XD, et al. Relation of CD4＋CD25＋ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 2004; 363: 608-15
|
|
|
|
|
|
9) Hartl D, Koller B, Mehlhorn AT, et al. Quantitative and functional impairment of pulmonary CD4＋CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol. 2007; 119: 1258-66
|
|
|
|
|
|
10) Flores-Borja F, Jury EC, Mauri C, et al. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2008; 105: 19396-401
|
|
|
|
|
|
11) Nguyen KD, Vanichsarn C, Fohner A, et al. Selective deregulation in chemokine signaling pathways of CD4＋CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma. J Allergy Clin Immunol. 2009; 123: 933-9 e10
|
|
|
|
|
|
12) Nguyen KD, Fohner A, Booker JD, et al. XCL1 enhances regulatory activities of CD4＋ CD25 (high) CD127(low/-) T cells in human allergic asthma. J Immunol. 2008; 181: 5386-95
|
|
|
|
|
|
13) Ahern D, Lloyd CM, Robinson DS. Chemokine responsiveness of CD4＋ CD25＋ regulatory and CD4＋ CD25- T cells from atopic and nonatopic donors. Allergy. 2009; 64: 1121-9
|
|
|
|
|
|
14) Kearley J, Barker JE, Robinson DS, et al. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4＋CD25＋ regulatory T cells is interleukin 10 dependent. J Exp Med. 2005; 202: 1539-47
|
|
|
|
|
|
15) Kearley J, Robinson DS, Lloyd CM. CD4＋CD25＋ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol. 2008; 122: 617-24 e6
|
|
|
|
|
|
16) Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007; 450: 566-9
|
|
|
|
|
|
17) Bardel E, Larousserie F, Charlot-Rabiega P, et al. Human CD4＋ CD25＋ Foxp3＋ regulatory T cells do not constitutively express IL-35. J Immunol. 2008; 181: 6898-905
|
|
|
|
|
|
18) Dao Nguyen X, Robinson DS. Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol. 2004; 114: 296-301
|
|
|
|
|
|
19) Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol. 2004; 114: 1425-33
|
|
|
|
|
|
20) Peek EJ, Richards DF, Faith A, et al. Interleukin-10-secreting “regulatory" T cells induced by glucocorticoids and beta2-agonists. Am J Respir Cell Mol Biol. 2005; 33: 105-11
|
|
|
|
|
|
21) Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006; 116: 146-55
|
|
|
|
|
|
22) Van Overtvelt L, Lombardi V, Razafindratsita A, et al. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol. 2008; 145: 152-62
|
|
|
|
|
|
23) Morgan RK, McAllister B, Cross L, et al. Histamine 4 receptor activation induces recruitment of FoxP3＋ T cells and inhibits allergic asthma in a murine model. J Immunol. 2007; 178: 8081-9
|
|
|
|
|
|
24) Hammad H, Kool M, Soullie T, et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med. 2007; 204: 357-67
|
|
|
|
|
|
25) Xanthou G, Alissafi T, Semitekolou M, et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med. 2007; 13: 570-8
|
|
|
|
|
|
26) Doganci A, Karwot R, Maxeiner JH, et al. IL-2 receptor beta-chain signaling controls immunosuppressive CD4＋ T cells in the draining lymph nodes and lung during allergic airway inflammation in vivo. J Immunol. 2008; 181: 1917-26
|
|
|
|
|
|
27) Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007; 13: 567-9
|
|
|
|
|
|
28) Smyth LJ, Starkey C, Vestbo J, et al. CD4-regulatory cells in COPD patients. Chest. 2007; 132: 156-63
|
|
|
|
|
|
29) Isajevs S, Taivans I, Strazda G, et al. Decreased FOXP3 expression in small airways of smokers with COPD. Eur Respir J. 2009; 33: 61-7
|
|
|
|
|
|
30) Ribeiro-Rodrigues R, Resende Co T, Rojas R, et al. A role for CD4＋CD25＋ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol. 2006; 144: 25-34
|
|
|
|
|
|
31) McKinley L, Logar AJ, McAllister F, et al. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J Immunol. 2006; 177: 6215-26
|
|
|
|
|
|
32) Kotsianidis I, Nakou E, Bouchliou I, et al. Global impairment of CD4＋CD25＋FOXP3＋ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009; 179: 1121-30
|
|
|
|
|
|
33) Mack DG, Lanham AM, Falta MT, et al. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am J Respir Crit Care Med. 2010; 181: 1241-9
|
|
|
|
|
|
34) Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med. 2006; 203: 359-70
|
|
|
|
|